MiR-122 regulates liver tolerance
Authors:
- Maytal GefenMGMaytal Gefen
- Shanny LayaniSLShanny Layani
- Emma KlahrEKEmma Klahr
- Zohar ShemuelianZSZohar Shemuelian
- Johannes BrandiJBJohannes Brandi
- Thomas JacobsTJThomas Jacobs
- Christiane SteegCSChristiane Steeg
- Lorenz AdlungLALorenz Adlung
- Christoph KilianCKChristoph Kilian
- Merav OrdanMOMerav Ordan
- Oren GordonOGOren Gordon
- Nathalie AbudiNANathalie Abudi
Open Access
- 29 August 2026
- journal article
- Published by Elsevier in JHEP Reports
- Vol. 8 (12)
Abstract
No abstract availableFunding Information
- Deutsche Forschungsgemeinschaft (SFB841)
This publication has 43 references indexed in Scilit:
- TNF in the liver: targeting a central player in inflammationSeminars in Immunopathology, 2022
- Histology activity index: a benchmark for decision makingHepatology International, 2022
- Hepatic fibrosis 2022: Unmet needs and a blueprint for the futureHepatology, 2021
- Osteopontin Takes Center Stage in Chronic Liver DiseaseHepatology, 2020
- Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4Annals of Hepatology, 2019
- The liver‐specific microRNA‐122*, the complementary strand of microRNA‐122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryHepatology, 2016
- Serum alkaline phosphatase levels accurately reflect cholestasis in miceHepatology, 2014
- Antitumor function of microRNA-122 against hepatocellular carcinomaJournal of Gastroenterology, 2014
- Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in MiceHepatology, 2013
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012